Rosecliff Acquisition I Quick Ratio (MDAI) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Rosecliff Acquisition Corp I  (NASDAQ: MDAI)

Rosecliff Acquisition I's Quick Ratio

MDAI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Rosecliff Acquisition I's Cash & cash equivalent grew by 20.12 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Rosecliff Acquisition I's Quick Ratio to 0.7, Quick Ratio remained below Rosecliff Acquisition Corp I average.

Within Medical Equipment & Supplies industry 129 other companies have achieved higher Quick Ratio than Rosecliff Acquisition I in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2042 to 2141.

Explain Quick Ratio?
How much Cash & cash equivalents MDAI´s has?
What are MDAI´s Current Liabilities?




MDAI Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
2026
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 29.92 % 31.43 % 12.21 % 20.64 % -5.17 %
Y / Y Cash & cash equivalent Change 33.33 % 10.75 % 198.62 % 183.5 % 52.68 %
Quick Ratio MRQ 0.7 0.55 0.78 0.67 0.69
MDAI's Total Ranking # 2141 # 2042 # 0 # 1798 #
Seq. Current Liabilities Change -6.6 % 7.45 % 25.58 % 3.09 % -5.52 %
Seq. Cash & cash equivalent Change 20.12 % -24.32 % 46.74 % -0.05 % -0.23 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 130
Healthcare Sector # 690
Overall Market # 2141


Quick Ratio Statistics
High Average Low
190.29 21.65 0.15
(Sep 30 2021)   (Mar 31 2022)




Financial Statements
Rosecliff Acquisition I's Current Liabilities $ 20 Millions Visit MDAI's Balance sheet
Rosecliff Acquisition I's Cash & cash equivalent $ 14 Millions Visit MDAI's Balance sheet
Source of MDAI's Sales Visit MDAI's Sales by Geography


Cumulative Rosecliff Acquisition I's Quick Ratio

MDAI's Quick Ratio for the trailling 12 Months

MDAI Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 23.34 % 14.45 % 10.43 % 22.65 % 23.19 %
Y / Y Cash & cash equivalent TTM Growth 72.51 % 82.98 % 81.2 % 43.68 % 36.93 %
Quick Ratio TTM 0.67 0.67 0.7 0.57 0.48
Total Ranking TTM # 4072 # 2914 # 0 # 3380 #
Seq. Current Liabilities TTM Growth 6.34 % 7.59 % 3.32 % 4.34 % -1.32 %
Seq. Cash & cash equivalent TTM Growth 7.28 % 2.41 % 27.93 % 22.73 % 13.8 %


On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the Q2 2026 to $19.87 millions, cumulative Quick Ratio remained unchanged at 0.67 below the Rosecliff Acquisition Corp I average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Rosecliff Acquisition I. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the from 2914 to 4072.

Explain Quick Ratio?
How much Cash & cash equivalents MDAI´s has?
What are MDAI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 905
Within the Market # 4072


trailing twelve months Quick Ratio Statistics
High Average Low
68.24 11.08 0.03
(Dec 31 2021)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions

Date modified: 2026-09-26T07:40:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.